A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women
Clinical trial NCT04556526 · COMPLETED
Trial details
- NCT number
- NCT04556526
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2023-03-02
- Enrollment
- 4031
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.